FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 0 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 1 |
| Most recent action | November 14, 2025 |
Enforcement history
On 2025-11-14, Argus HQ recorded an FDA Form 483 inspection citation for Asahi Kasei Finechem Co., Ltd., rated "high" severity in Argus HQ's classification: Asahi Kasei Finechem Co., Ltd. -- FDA 483: 1 observation (2025-11-14). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Asahi Kasei Finechem Co., Ltd. has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- How many FDA actions does Argus HQ track for Asahi Kasei Finechem Co., Ltd.?
- 1 total: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.
- What is the most recent FDA action on file for Asahi Kasei Finechem Co., Ltd.?
- November 14, 2025. Argus HQ ingests new FDA enforcement records daily.
- Is this FDA enforcement data for Asahi Kasei Finechem Co., Ltd. official?
- Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
- How many FDA actions has Asahi Kasei Finechem Co., Ltd. had?
- Argus HQ has recorded 1 FDA events for Asahi Kasei Finechem Co., Ltd.: 0 warning letters, 0 recalls, 0 approvals, and 1 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2025). Asahi Kasei Finechem Co., Ltd.'s Complete FDA Record. Digital Empire LLC. Retrieved from https://argushq.ai/company/asahi-kasei-finechem-co-ltd
"Asahi Kasei Finechem Co., Ltd.'s Complete FDA Record." Argus HQ Research, Digital Empire LLC, 2025, argushq.ai/company/asahi-kasei-finechem-co-ltd.
Argus HQ Research. "Asahi Kasei Finechem Co., Ltd.'s Complete FDA Record." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/asahi-kasei-finechem-co-ltd.
@misc{argushq_argushq_ai_company_asahi_kasei_finechem_co_ltd_2025,
title = {Asahi Kasei Finechem Co., Ltd.'s Complete FDA Record},
author = {{Argus HQ Research}},
year = {2025},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/company/asahi-kasei-finechem-co-ltd},
note = {Accessed: July 13, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗